The potential hepatoprotective effects of lovastatin combined with oral hypoglycemic agents in streptozotocin-induced diabetes in rats.

Conclusions: Hepatic complications associated with diabetes could be improved by combination of metformin or gliclazide with lovastatin.
PMID: 32114843 [PubMed - as supplied by publisher]

Source: Immunopharmacology and Immunotoxicology - March 3, 2020 Category: Allergy & Immunology Tags: Immunopharmacol Immunotoxicol Source Type: research